Cannabinoid Biosciences Acquires CannabidiolHemp
November 25, 2019
Cannabinoid Biosciences, Inc., a California-based biopharmaceutical subsidiary of Kid Castle, has acquired CannabidiolHemp (CannabidiolHemp.net), a CBD quality aggregator and validator. The purchase is the first of multiple planned acquisitions intended to build a vertically integrated CBD distribution and supply-chain business across the United States and Canada.
- Buyers
- Cannabinoid Biosciences, Inc., Kid Castle
- Targets
- CannabidiolHemp
- Industry
- Consumer Products
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Nexus Agriscience Acquires Biotech Institute Hemp Division IP Portfolio
January 27, 2026
Healthcare Services
Nexus Agriscience acquired the hemp division and associated intellectual property (IP) portfolio of Biotech Institute to expand its molecular farming platform. The deal includes issued and pending utility and plant patents, proprietary germplasm, seed inventory and living plant materials, with Biotech Institute leaders joining Nexus in governance and technical roles.
-
The Cannabist Company Acquires Ciencia Labs Portfolio
December 11, 2024
Retail
The Cannabist Company (formerly Columbia Care) acquired the Ciencia Labs portfolio earlier in 2024 and is launching the Ciencia Labs brand dreamt in Maryland, with additional markets and products planned for 2025. The acquisition expands The Cannabist Company’s branded product offerings and supports broader retail and wholesale distribution across its dispensary and wholesale channels.
-
GenCanna Acquires CBD Capital Ltd
September 1, 2021
Manufacturing
GenCanna, a Kentucky-based vertically integrated CBD manufacturer, has acquired London-based CBD Capital Ltd to expand its bulk ingredient and finished-goods operations across the United Kingdom, the European Union and other global markets. The deal broadens GenCanna’s formulation and distribution capabilities in Europe; CBD Capital CEO Hassan Akhtar will remain in his role.
-
Bruker Corporation Acquires Canopy Biosciences, LLC
September 11, 2020
Biotechnology
Bruker Corporation has acquired Canopy Biosciences, LLC to strengthen its targeted multi-omics and high-plex biomarker imaging capabilities, adding Canopy's ChipCytometry platform and multi-omics services. Financial terms were not disclosed; Ampersand Capital Partners was identified as Canopy's lead investor.
-
Bayou City Hemp Company Acquires LeafLife Wellness
June 18, 2020
Consumer Products
Bayou City Hemp Company, Inc., a Houston-based hemp processing and extraction company, has completed the acquisition of Leaf Life, Inc. (LeafLife Wellness), a Dallas-based CBD retail company that formulates, manufactures and distributes CBD-infused skincare, cosmetics and wellness products. The acquisition vertically integrates Bayou City Hemp’s supply chain—LeafLife will use Bayou City Hemp distillate and isolate—and expands the acquirer’s retail, white-label and online distribution capabilities; the deal is expected to be accretive to earnings.
-
Pressure BioSciences Announces Plan to Acquire Cannaworx, Inc.
April 29, 2020
Biotechnology
Pressure BioSciences signed a binding letter of intent to merge with Cannaworx, Inc., bringing Cannaworx's portfolio of hemp-derived CBD, cosmeceutical, nutraceutical and veterinary products into PBI's public company. Post-transaction, Cannaworx products are expected to utilize PBI's Ultra Shear Technology to create stable, highly bioabsorbable nanoemulsions and to accelerate product commercialization across consumer, veterinary and agricultural markets.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.